1. Acknowledgment to Referees

   Acknowledgement to Referees 21 November 2018 Pages: 1027 - 1030

2. Recombinant Zoster Vaccine (Shingrix^®): A Review in Herpes Zoster

   • Yahiya Y. Syed

   Adis Drug Evaluation 29 October 2018 Pages: 1031 - 1040

   

3. Adjunctive Therapies in Parkinson’s Disease: How to Choose the Best Treatment Strategy Approach

   • Margherita Fabbri
   • Mario M. Rosa
   • Joaquim J. Ferreira

   Therapy in Practice 15 October 2018 Pages: 1041 - 1054

   

4. Hematopoietic Cell Transplant (HCT) in the Elderly: Myths, Controversies and Unknowns

   • Zeina Al-Mansour
   • Muthalagu Ramanathan
   • Jan Cerny

   Review Article 09 October 2018 Pages: 1055 - 1064

   

5. Evidence-Based Management of Diabetes in Older Adults

   • Arshag D. Mooradian

   Review Article 10 October 2018 Pages: 1065 - 1078

   

6. Efficacy of a Standardized Oral Vitamin D Dosing Regimen in Nursing Home Residents

   • Marlous Toren-Wielema
   • Ruth Veenhuizen
   • Eric van Roon

   Short Communication 22 October 2018 Pages: 1079 - 1087

   

7. Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities

   • Matthew Alcusky
   • Anne L. Hume
   • Kate L. Lapane

   Short Communication 13 November 2018 Pages: 1089 - 1098

   

8. Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation

   • Federico Rea
   • Giulia Calusi
   • the I-GrADE Investigators

   Original Research Article 26 October 2018 Pages: 1099 - 1108

   

9. Safety, Tolerability and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy in Patients Aged ≥ 65 Years with Focal Seizures

   • Raquel Costa
   • Bernhard Steinhoff
   • Patrício Soares-da-Silva

   Original Research Article Open access 01 November 2018 Pages: 1109 - 1117

10. Comment on: “Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)”

    • Maurizio Stefani

    Letter to the Editor 27 October 2018 Pages: 1119 - 1120

11. Authors’ Reply to Stefani: “Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)”

    • Ane Erdal
    • Dagrun D. Slettebo
    • Bettina S. Husebo

    Letter to the Editor 27 October 2018 Pages: 1121 - 1122